Literature DB >> 11432960

Genotype-phenotype correlation in hereditary multiple exostoses.

C Francannet1, A Cohen-Tanugi, M Le Merrer, A Munnich, J Bonaventure, L Legeai-Mallet.   

Abstract

Hereditary multiple exostoses (HME) is a genetically heterogeneous autosomal dominant disorder characterised by the development of bony protuberances mainly located on the long bones. Three HME loci have been mapped to chromosomes 8q24 (EXT1), 11p11-13 (EXT2), and 19p (EXT3). The EXT1 and EXT2 genes encode glycosyltransferases involved in biosynthesis of heparan sulphate proteoglycans. Here we report on a clinical survey and mutation analysis of 42 HME French families and show that EXT1 and EXT2 accounted for more than 90% of HME cases in our series. Among them, 27/42 cases were accounted for by EXT1 (64%, four nonsense, 19 frameshift, three missense, and one splice site mutations) and 9/42 cases were accounted for by EXT2 (21%, four nonsense, two frameshift, two missense, and one splice site mutation). Overall, 31/36 mutations were expected to cause loss of protein function (86%). The most severe forms of the disease and malignant transformation of exostoses to chondrosarcomas were associated with EXT1 mutations. These findings provide the first genotype-phenotype correlation in HME and will, it is hoped, facilitate the clinical management of these patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432960      PMCID: PMC1757186          DOI: 10.1136/jmg.38.7.430

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  28 in total

1.  Identification and localization of the gene for EXTL, a third member of the multiple exostoses gene family.

Authors:  C A Wise; G A Clines; H Massa; B J Trask; M Lovett
Journal:  Genome Res       Date:  1997-01       Impact factor: 9.043

2.  Positional cloning of a gene involved in hereditary multiple exostoses.

Authors:  W Wuyts; W Van Hul; J Wauters; M Nemtsova; E Reyniers; E V Van Hul; K De Boulle; B B de Vries; J Hendrickx; I Herrygers; P Bossuyt; W Balemans; E Fransen; L Vits; P Coucke; N J Nowak; T B Shows; L Mallet; A M van den Ouweland; J McGaughran; D J Halley; P J Willems
Journal:  Hum Mol Genet       Date:  1996-10       Impact factor: 6.150

3.  The natural history of hereditary multiple exostoses.

Authors:  G A Schmale; E U Conrad; W H Raskind
Journal:  J Bone Joint Surg Am       Date:  1994-07       Impact factor: 5.284

4.  An extension of the admixture test for the study of genetic heterogeneity in hereditary multiple exostoses.

Authors:  L Legeai-Mallet; P Margaritte-Jeannin; M Lemdani; M Le Merrer; H Plauchu; P Maroteaux; A Munnich; F Clerget-Darpoux
Journal:  Hum Genet       Date:  1997-03       Impact factor: 4.132

5.  Hereditary multiple exostoses (EXT): mutational studies of familial EXT1 cases and EXT-associated malignancies.

Authors:  J T Hecht; D Hogue; Y Wang; S H Blanton; M Wagner; L C Strong; W Raskind; M F Hansen; D Wells
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

6.  Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1).

Authors:  J Ahn; H J Lüdecke; S Lindow; W A Horton; B Lee; M J Wagner; B Horsthemke; D E Wells
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

7.  A gene for hereditary multiple exostoses maps to chromosome 19p.

Authors:  M Le Merrer; L Legeai-Mallet; P M Jeannin; B Horsthemke; A Schinzel; H Plauchu; A Toutain; F Achard; A Munnich; P Maroteaux
Journal:  Hum Mol Genet       Date:  1994-05       Impact factor: 6.150

8.  The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes.

Authors:  D Stickens; G Clines; D Burbee; P Ramos; S Thomas; D Hogue; J T Hecht; M Lovett; G A Evans
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

9.  Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8.

Authors:  J T Hecht; D Hogue; L C Strong; M F Hansen; S H Blanton; M Wagner
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

10.  Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11.

Authors:  W H Raskind; E U Conrad; H Chansky; M Matsushita
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

View more
  54 in total

1.  A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses.

Authors:  Kazu Matsumoto; Fumitoshi Irie; Susan Mackem; Yu Yamaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Genetic screening of EXT1 and EXT2 in Cypriot families with hereditary multiple osteochondromas.

Authors:  George A Tanteles; Michael Nicolaou; Vassos Neocleous; Christos Shammas; Maria A Loizidou; Angelos Alexandrou; Elena Ellina; Nasia Patsia; Carolina Sismani; Leonidas A Phylactou; Violetta Christophidou-Anastasiadou
Journal:  J Genet       Date:  2015-12       Impact factor: 1.166

3.  Osteochondroma causing diaphragmatic rupture and bowel obstruction in a 14-year-old boy.

Authors:  Fizan Abdullah; Robert Kanard; Dominic Femino; Henri Ford; James Stein
Journal:  Pediatr Surg Int       Date:  2006-01-03       Impact factor: 1.827

4.  Genetic analysis of hereditary multiple exostoses in Tunisian families: a novel frame-shift mutation in the EXT1 gene.

Authors:  Sana Sfar; Abderrazak Abid; Wijden Mahfoudh; Houyem Ouragini; Farah Ouechtati; Sonia Abdelhak; Lotfi Chouchane
Journal:  Mol Biol Rep       Date:  2008-03-11       Impact factor: 2.316

Review 5.  Glycobiology and the growth plate: current concepts in multiple hereditary exostoses.

Authors:  Kevin B Jones
Journal:  J Pediatr Orthop       Date:  2011 Jul-Aug       Impact factor: 2.324

6.  [Hereditary bone tumors].

Authors:  D Baumhoer
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

Review 7.  Osteochondromas: An Updated Review of Epidemiology, Pathogenesis, Clinical Presentation, Radiological Features and Treatment Options.

Authors:  Kostas Tepelenis; Georgios Papathanakos; Aikaterini Kitsouli; Theodoros Troupis; Alexandra Barbouti; Konstantinos Vlachos; Panagiotis Kanavaros; Panagiotis Kitsoulis
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

8.  The molecular and cellular basis of exostosis formation in hereditary multiple exostoses.

Authors:  Meirav Trebicz-Geffen; Dror Robinson; Zoharia Evron; Tova Glaser; Mati Fridkin; Yehuda Kollander; Israel Vlodavsky; Neta Ilan; Kit Fong Law; Kathryn S E Cheah; Danny Chan; Haim Werner; Zvi Nevo
Journal:  Int J Exp Pathol       Date:  2008-04-30       Impact factor: 1.925

9.  Multiple osteochondromas: clinicopathological and genetic spectrum and suggestions for clinical management.

Authors:  Liesbeth Hameetman; Judith Vmg Bovée; Antonie Hm Taminiau; Herman M Kroon; Pancras Cw Hogendoorn
Journal:  Hered Cancer Clin Pract       Date:  2004-11-15       Impact factor: 2.857

10.  Mutation screening of EXT1 and EXT2 by denaturing high-performance liquid chromatography, direct sequencing analysis, fluorescence in situ hybridization, and a new multiplex ligation-dependent probe amplification probe set in patients with multiple osteochondromas.

Authors:  Ivy Jennes; Mark M Entius; Els Van Hul; Alessandro Parra; Luca Sangiorgi; Wim Wuyts
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.